AR和YAP交叉:对前列腺癌治疗策略的影响
Guansong Zheng1, Zhaojie Yan1, Junrong Zou2,3,4
1First Clinical College, Gannan Medical University, Ganzhou, China.
Frontiers in oncology
|February 18, 2025
概括
这篇评论探讨了前列腺癌中雄激素受体 (AR) 和Hippo-YAP信号通路之间的相互作用. 了解这种交叉通话是克服治疗阻力和开发晚期前列腺癌新疗法的关键.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 细胞信号传递 细胞信号传递
背景情况:
- 前列腺癌是男性常见的恶性瘤,受体 (AR) 途径是其发展的核心.
- 目前的抗雄激素疗法往往对割抵抗性前列腺癌 (CRPC) 无效.
- Hippo-YAP信号通路越来越多地与前列腺癌有关,显示与AR通路的交叉声.
研究的目的:
- 审查在前列腺癌中AR和Hippo-YAP信号通路之间的相互作用的分子机制.
- 阐明AR和YAP在前列腺癌发病,进展和治疗耐药性的作用.
- 讨论针对前列腺癌中YAP途径的治疗潜力.
主要方法:
- 对调查前列腺癌中AR和YAP信号的研究进行文献综述.
- 分析AR-YAP交叉的分子机制,包括转录,翻译和后翻译调节.
- 检查关于YAP在前列腺癌中的作用的临床前和临床数据.
主要成果:
- 通过转录,转化和酸化调节,AR影响YAP的稳定性和功能.
- YAP对AR表现出双重监管效应,促进或抑制其活动.
- AR-YAP轴在前列腺癌的发展,进展和对治疗的耐药性方面发挥着重要作用.
结论:
- 在前列腺癌的发病过程中,AR和YAP之间的复杂交叉是至关重要的.
- 准YAP途径是克服前列腺癌治疗耐药性的有希望的治疗策略.
- 对AR-YAP相互作用的进一步研究可能会产生新的临床应用.
相关概念视频
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
02:49Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
01:26Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
129
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
129
02:50Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
02:23Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
01:19Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K